Clinical Trial Update: A Clinical Study in Subjects With Neuropathic Pain From PHN Who Have Had an Inadequate Response to Gabapentin Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical study in postherpetic neuralgia patients who had an inadequate response to gabapentin; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postherpetic Neuralgia

Drugs mentioned

• Gabapentin (Gabapentin)

Snippet

Sponsor: XenoPort, Inc. | Conditions: Neuralgia, Postherpetic | Phase 2 | Status: COMPLETED | Results posted: 2011-05-20